Records containing: Latent Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-07-24Phase I/II Dose Finding and Safety Study of Rifapentine and Isoniazid in HIV-Infected and HIV-Uninfected Children With Latent Tuberculosis Infection
-
CLINICAL_TRIALS study results posted · 2026-07-09A Brief Educational Video for Patients Prescribed Latent Tuberculosis Treatment: A Randomized Trial in an Integrated Healthcare Organization in the United States
-
CLINICAL_TRIALS study record update · 2026-04-14Natural History of Tuberculosis
-
CLINICAL_TRIALS study record update · 2026-04-132R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB: a 3-arm Randomized Trial.
-
CLINICAL_TRIALS study record update · 2026-01-21One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-22TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
-
CLINICAL_TRIALS study record update · 2025-09-09A Brief Educational Video for Patients Prescribed Latent Tuberculosis Treatment: A Randomized Trial in an Integrated Healthcare Organization in the United States
-
CLINICAL_TRIALS study record update · 2025-06-10TB Screening Improves Preventive Therapy Uptake Trial
-
CLINICAL_TRIALS study record update · 2025-06-08Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in Uganda
-
CLINICAL_TRIALS study record update · 2025-06-03Phase I/II Dose Finding and Safety Study of Rifapentine and Isoniazid in HIV-Infected and HIV-Uninfected Children With Latent Tuberculosis Infection
-
CLINICAL_TRIALS study record update · 2025-05-09Economic Incentives and Video Directly Observed Therapy to Promote Adherence to Latent Tuberculosis Infection
-
CLINICAL_TRIALS study record update · 2025-03-19Evaluating the Accuracy of New Tests for TB Infection Diagnosis
-
CLINICAL_TRIALS study record update · 2025-01-22Investigating the Impact of the Pulmonary Innate Immune Response and Microbiome After Exposure to Mycobacterium Tuberculosis
-
CLINICAL_TRIALS study record update · 2024-12-24Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
-
CLINICAL_TRIALS study record update · 2024-09-26Six Weeks of Daily Rifapentine vs. a Comparator Arm of 12-16 Week Rifamycin-based Treatment of Latent M. Tuberculosis Infection: Assessment of Safety, Tolerability and Effectiveness
-
CLINICAL_TRIALS study record update · 2024-07-19Improving Rhode Island's Tuberculosis Preventive Services in Primary Care: A Mixed-Methods Evaluation of an Innovative Telementoring Model
-
CLINICAL_TRIALS study record update · 2024-07-15Acquisition and Persistence of Rifampicin Resistance in Staphylococcus Aureus During and After Treatment for Latent Tuberculosis
-
CLINICAL_TRIALS study record update · 2024-07-08Uptake, Effectiveness and Acceptability of Routine Screening of Pregnant Migrants for Latent Tuberculosis Infection in Antenatal Care: a Feasibility Study
-
CLINICAL_TRIALS study record update · 2024-06-18New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
-
CLINICAL_TRIALS study record update · 2024-05-09COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB)
-
CLINICAL_TRIALS study record update · 2024-03-15Comparison of 3-month Once-weekly Isoniazid Plus Rifapentine, 4-month Daily Rifampicin, and 3-month Daily Isoniazid Plus Rifampicin for the Treatment Latent Tuberculosis in Patients With End-stage Kidney Disease: A Randomised Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-02-13Cross-sectional Study on Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students. A GENERATOR Infrastructure.
-
CLINICAL_TRIALS study record update · 2024-01-03Evaluation of Clinical Practice Guidelines and Educational Decision-support Tools on Medical Trainees' Confidence With Latent Tuberculosis (LTBI) Testing and Treatment: A Randomized Trial
-
CLINICAL_TRIALS study record update · 2023-11-22A Cross-sectional Study to Estimate the Influence of Malnutrition, Diabetes Mellitus and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population
-
CLINICAL_TRIALS study record update · 2023-11-07Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention: the 3HP Options Implementation Trial